These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis. Han S; Arvai AS; Clancy SB; Tainer JA J Mol Biol; 2001 Jan; 305(1):95-107. PubMed ID: 11114250 [TBL] [Abstract][Full Text] [Related]
23. Molecular heterogeneity of a type III cytotoxin, Pseudomonas aeruginosa exoenzyme S. Maresso AW; Riese MJ; Barbieri JT Biochemistry; 2003 Dec; 42(48):14249-57. PubMed ID: 14640693 [TBL] [Abstract][Full Text] [Related]
24. Functional domains of Pseudomonas aeruginosa exoenzyme S. Knight DA; Finck-Barbançon V; Kulich SM; Barbieri JT Infect Immun; 1995 Aug; 63(8):3182-6. PubMed ID: 7622246 [TBL] [Abstract][Full Text] [Related]
25. The amino-terminal domain of Pseudomonas aeruginosa ExoS disrupts actin filaments via small-molecular-weight GTP-binding proteins. Pederson KJ; Vallis AJ; Aktories K; Frank DW; Barbieri JT Mol Microbiol; 1999 Apr; 32(2):393-401. PubMed ID: 10231494 [TBL] [Abstract][Full Text] [Related]
26. Intracellular targeting of exoenzyme S of Pseudomonas aeruginosa via type III-dependent translocation induces phagocytosis resistance, cytotoxicity and disruption of actin microfilaments. Frithz-Lindsten E; Du Y; Rosqvist R; Forsberg A Mol Microbiol; 1997 Sep; 25(6):1125-39. PubMed ID: 9350868 [TBL] [Abstract][Full Text] [Related]
27. Exoenzyme S from P. aeruginosa ADP ribosylates rab4 and inhibits transferrin recycling in SLO-permeabilized reticulocytes. Bette-Bobillo P; Giro P; Sainte-Marie J; Vidal M Biochem Biophys Res Commun; 1998 Mar; 244(2):336-41. PubMed ID: 9514923 [TBL] [Abstract][Full Text] [Related]
28. Structure-activity relationships for inhibitors of Pseudomonas aeruginosa exoenzyme S ADP-ribosyltransferase activity. Saleeb M; Sundin C; Aglar Ö; Pinto AF; Ebrahimi M; Forsberg Å; Schüler H; Elofsson M Eur J Med Chem; 2018 Jan; 143():568-576. PubMed ID: 29207339 [TBL] [Abstract][Full Text] [Related]
29. ADP-ribosylation of p21ras and related proteins by Pseudomonas aeruginosa exoenzyme S. Coburn J; Gill DM Infect Immun; 1991 Nov; 59(11):4259-62. PubMed ID: 1937783 [TBL] [Abstract][Full Text] [Related]
30. Modification of Ras in eukaryotic cells by Pseudomonas aeruginosa exoenzyme S. McGuffie EM; Frank DW; Vincent TS; Olson JC Infect Immun; 1998 Jun; 66(6):2607-13. PubMed ID: 9596723 [TBL] [Abstract][Full Text] [Related]
31. Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III pathway. Yahr TL; Goranson J; Frank DW Mol Microbiol; 1996 Dec; 22(5):991-1003. PubMed ID: 8971719 [TBL] [Abstract][Full Text] [Related]
32. Pseudomonas aeruginosa exoenzyme S ADP-ribosylates Ras at multiple sites. Ganesan AK; Frank DW; Misra RP; Schmidt G; Barbieri JT J Biol Chem; 1998 Mar; 273(13):7332-7. PubMed ID: 9516428 [TBL] [Abstract][Full Text] [Related]
33. ADP-ribosylation by exoenzyme T of Pseudomonas aeruginosa induces an irreversible effect on the host cell cytoskeleton in vivo. Sundin C; Hallberg B; Forsberg A FEMS Microbiol Lett; 2004 May; 234(1):87-91. PubMed ID: 15109724 [TBL] [Abstract][Full Text] [Related]
34. Expression and purification of two recombinant forms of the type-III cytotoxin, Pseudomonas aeruginosa ExoS. Maresso AW; Barbieri JT Protein Expr Purif; 2002 Dec; 26(3):432-7. PubMed ID: 12460767 [TBL] [Abstract][Full Text] [Related]
35. Genetic analysis of exoenzyme S expression by Pseudomonas aeruginosa. Goranson J; Frank DW FEMS Microbiol Lett; 1996 Jan; 135(2-3):149-55. PubMed ID: 8595851 [TBL] [Abstract][Full Text] [Related]
36. A nonphosphorylated 14-3-3 binding motif on exoenzyme S that is functional in vivo. Henriksson ML; Francis MS; Peden A; Aili M; Stefansson K; Palmer R; Aitken A; Hallberg B Eur J Biochem; 2002 Oct; 269(20):4921-9. PubMed ID: 12383250 [TBL] [Abstract][Full Text] [Related]
37. The ADP-ribosyltransferase domain of the effector protein ExoS inhibits phagocytosis of Pseudomonas aeruginosa during pneumonia. Rangel SM; Logan LK; Hauser AR mBio; 2014 Jun; 5(3):e01080-14. PubMed ID: 24917597 [TBL] [Abstract][Full Text] [Related]
38. Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S. Fleiszig SM; Wiener-Kronish JP; Miyazaki H; Vallas V; Mostov KE; Kanada D; Sawa T; Yen TS; Frank DW Infect Immun; 1997 Feb; 65(2):579-86. PubMed ID: 9009316 [TBL] [Abstract][Full Text] [Related]
39. Polarisation of type III translocation by Pseudomonas aeruginosa requires PcrG, PcrV and PopN. Sundin C; Thelaus J; Bröms JE; Forsberg A Microb Pathog; 2004 Dec; 37(6):313-22. PubMed ID: 15619427 [TBL] [Abstract][Full Text] [Related]
40. Ezrin/radixin/moesin proteins are high affinity targets for ADP-ribosylation by Pseudomonas aeruginosa ExoS. Maresso AW; Baldwin MR; Barbieri JT J Biol Chem; 2004 Sep; 279(37):38402-8. PubMed ID: 15252013 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]